Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford, in association with the John Black Charitable Foundation, is pleased to welcome Dr Ira Milosevic as a John Black Senior Research Fellow in Parkinson’s Disease Research.

Ira Milosevic

The John Black Senior Research Fellowship aims to build on the strengths of the University's Central Nervous System (CNS) research programmes and world leading research into the discovery and translation of novel therapeutic approaches for neurodegenerative diseases, with a particular focus on Parkinson's disease. As a principal investigator, Dr Milosevic will provide strategic and academic leadership, pioneering studies and development of worldwide scientific collaborations.

"My colleagues and I are delighted to be welcoming Dr Milosevic to the University of Oxford and Nuffield Department of Medicine", says Dr Davis, CSO of the ARUK Oxford Drug Discovery Institute (ODDI), "Disturbances in the normal function of subcellular organelles has been highlighted as a possible cause of several neurodegenerative diseases and Ira's expertise in the field will provide a major boost to expansion of our understanding of the functional genetics of Parkinson's disease, in particular".

Dr Milosevic, who joins the University from the European Neuroscience Institute – Göttingen, said: "I am honoured to accept the John Black Senior Research Fellowship and excited to be joining the University of Oxford. I am extremely grateful to the John Black Charitable Foundation for providing financial support and for their efforts to promote translational research in Parkinson's disease. I look forward to helping advance their important mission and to collaborating with the exceptional faculty and students at the Nuffield Department of Medicine and Wellcome Centre for Human Genetics. "

About the John Black Charitable Foundation

John Black Charitable Foundation (JBCF) was created out of the Will of the Late John Black. The aim of JBCF is to promote quality research in the areas of Parkinson's disease and Prostate Cancer. Since its inception, JBCF has committed substantial funding for a large number of research projects at many of the UK's leading institutions.

Similar stories

Alternating vaccines trial expands to include two additional vaccines

Clinical Trials Coronavirus COVID-19 General

Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.

Oxford medical students launch flagship raffle in aid of NHS heroes and lifesaving medical equipment

General

Tingewick, a society formed of medical students from Oxford University, are hosting a virtual charity raffle. With over 70 amazing prizes, ranging from Truck festival tickets to restaurant vouchers to bags of books and even a bike, the raffle is an exciting way to celebrate lockdown lifting by supporting many wonderful Oxfordshire businesses whilst raising lots of money for charity.

UK and EU regulators conclude benefits of vaccination continue to outweigh the risks

Coronavirus COVID-19 General

Today, the medical regulators in the UK and Europe have announced their conclusions from their reviews of very rare cases of unusual blood clots in people who have received the Oxford-AstraZeneca coronavirus vaccine.

Link between COVID-19 infection and subsequent mental health and neurological conditions found

Coronavirus COVID-19 General Research

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.

New national study of long-term impacts of debilitating lung damage from COVID-19

Coronavirus COVID-19 General Research

A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability.